-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Gain Therapeutics, Inc. quarterly and annual Share-based Payment Arrangement, Expense history and change rate from Q2 2021 to Q3 2025.
- Gain Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $460,005, a 28.7% increase year-over-year.
- Gain Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $-438,877, a 117% decline year-over-year.
- Gain Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $190,424, a 94.2% decline from 2023.
- Gain Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3,259,026, a 114% increase from 2022.
- Gain Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1,526,434, a 81.9% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)